Coagulation and fibrinolysis during coronary artery bypass grafting using a new heparin-coated surface

被引:0
|
作者
Johnell, M
Larsson, R
Thelin, S
Siegbahn, A
机构
[1] Univ Uppsala Hosp, Dept Oncol, Lab Coagulat Res, S-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Radiol, S-75185 Uppsala, Sweden
[3] Univ Uppsala Hosp, Dept Clin Immunol & Cardiothorac Surg, S-75185 Uppsala, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
773
引用
收藏
页码:246 / 246
页数:1
相关论文
共 50 条
  • [1] Coagulation, fibrinolysis, and cell activation in patients and in shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface
    Baufreton, C
    de Brux, JL
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (06): : 2116 - 2116
  • [2] Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface
    Johnell, M
    Elgue, G
    Larsson, R
    Larsson, A
    Thelin, S
    Siegbahn, A
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 124 (02): : 321 - 332
  • [3] Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting
    Mirow, N
    Minami, K
    KLeikamp, G
    Tenderich, G
    Puhlmann, T
    Körfer, R
    THORACIC AND CARDIOVASCULAR SURGEON, 2001, 49 (03): : 131 - 136
  • [4] Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting
    Jansen, PGM
    Baufreton, C
    LeBesnerais, P
    Loisance, DY
    Wildevuur, CRH
    ANNALS OF THORACIC SURGERY, 1996, 61 (05): : 1363 - 1366
  • [5] EFFECTS ON COAGULATION AND FIBRINOLYSIS WITH REDUCED VERSUS FULL SYSTEMIC HEPARINIZATION AND HEPARIN-COATED CARDIOPULMONARY BYPASS
    OVRUM, E
    BROSSTAD, F
    HOLEN, EA
    TANGEN, G
    ABDELNOOR, M
    CIRCULATION, 1995, 92 (09) : 2579 - 2584
  • [6] Clinical evaluation of heparin-coated circuits for routine coronary artery bypass grafting surgery:: A prospective randomized study
    Collart, F
    Caus, T
    Pomane, C
    Pellissier, V
    Chi, Y
    Montiès, JR
    Mesana, T
    ARTIFICIAL ORGANS, 2000, 24 (08) : 611 - 613
  • [7] Complete heparin-coated (CBAS) cardio-pulmonary bypass and reduced systemic heparin dose; Effects on coagulation and fibrinolysis
    Ovrum, E
    Brosstad, F
    Holen, EA
    Tangen, G
    Abdelnoor, M
    Oystese, R
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1996, 10 (06) : 449 - 455
  • [8] Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery
    Horimoto, H
    Kondo, K
    Asada, K
    Sasaki, S
    ARTIFICIAL ORGANS, 1996, 20 (08) : 936 - 940
  • [9] PLATELET AND COAGULATION ACTIVATION BY HEPARIN-COATED CARDIOPULMONARY BYPASS SYSTEMS
    KOTTKEMARCHANT, K
    BORSCH, J
    MCCARTHY, P
    LAASCH, C
    BROOKS, L
    MUEHRCKE, D
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1344 - 1344
  • [10] Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery
    Ovrum, E
    Tangen, G
    Oystese, R
    Ringdal, MAL
    Istad, R
    JOURNAL OF CARDIAC SURGERY, 2003, 18 (02) : 140 - 146